Drug Profile
Research programme: Escherichia coli vaccine - Mutabilis
Alternative Names: Escherichia coli vaccine research programme - Mutabilis; ExPEC vaccineLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Mutabilis
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Escherichia coli infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Escherichia-coli-infections in France
- 16 May 2005 Escherichia coli vaccine is available for licensing (http://www.mutabilis.fr)
- 16 May 2005 Preclinical trials in Escherichia coli infections in France (unspecified route)